We'd appreciate your feedback. Send feedback Subscribe to our newsletters and alerts


Annals of Pharmacy Practice and Pharmacotherapy

2021 Volume 1

Community Pharmacy-Based Study on Managing Upper Gastrointestinal Symptoms in Italy


, ,
  1. Department of Clinical Pharmacy, College of Pharmacy, Seoul National University, Seoul, South Korea.
Abstract

Upper gastrointestinal (GI) symptoms are commonly reported by patients visiting community pharmacies in Italy, yet their prior treatment history is often not well documented. This descriptive, cross-sectional study investigated the medication use of individuals experiencing upper GI symptoms who visited one of 20 participating community pharmacies over a 7-month period, using a structured questionnaire. Among 1,020 respondents, 62.1 percent had previously sought medical consultation. The most frequently reported symptom was epigastric burning (31.8 percent), followed by acid regurgitation (14.6 percent) and postprandial fullness (12.0 percent). Out of 1,609 recorded treatments, proton pump inhibitors were the most commonly used class (35.6 percent), followed by antacids (17.5 percent) and alginate-based products (17.2 percent). Notably, 38.1 percent of patients managed their symptoms without medical guidance, and 42.0% relied on non-prescription medications. These findings indicate that community pharmacies could play an enhanced role in supporting patients with GI disorders to ensure safer self-medication practices.


How to cite this article
Vancouver
Singh J, Kim E, Lee V. Community Pharmacy-Based Study on Managing Upper Gastrointestinal Symptoms in Italy. Ann Pharm Pract Pharmacother. 2021;1:54-64. https://doi.org/10.51847/ulDiG1HiDj
APA
Singh, J., Kim, E., & Lee, V. (2021). Community Pharmacy-Based Study on Managing Upper Gastrointestinal Symptoms in Italy. Annals of Pharmacy Practice and Pharmacotherapy, 1, 54-64. https://doi.org/10.51847/ulDiG1HiDj

About GalaxyPub

Find out more

Our esteemed publisher is committed to advancing medical knowledge through rigorous research dissemination. We exclusively accept submissions related to the field of medicine.

Our journals provide a platform for clinicians, researchers, and scholars to share groundbreaking discoveries, clinical insights, and evidence-based practices. By maintaining this specialized focus, we ensure that their publications contribute significantly to the advancement of healthcare worldwide.